Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal E-Jurnal Medika Udayana Ophthalmologica Indonesiana
Putu Anindya Agrasidi
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
KARAKTERISTIK PENDERITA PTERIGIUM DI DESA TIANYAR KARANGASEM TAHUN 2015 Putu Anindya Agrasidi
E-Jurnal Medika Udayana Vol 7 No 7 (2018): Vol 7 No 7 (2018): E-Jurnal Medika Udayana
Publisher : Universitas Udayana

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (142.187 KB)

Abstract

Pterigium merupakan suatu pertumbuhan neoformasi fibrovaskuler non malignan, bentuknya menyerupai sayap pada permukaan okular mata yang dapat mengganggu pengelihatan. Beberapa teori tentang patogenesis pterigium yang berkembang sekarang antara lain teori degenerasi, inflamasi, tropik, serta teori yang menghubungkan dengan sinar UV. Penelitian ini bertujuan untuk mengetahui distribusi dan frekuensi karakteristik pterigium di Desa Tianyar Karangasem. Penelitian ini bersifat deskriptif dengan pendekatan cross-sectional, dilakukan di Desa Tianyar Karangasem pada 24 Maret 2015. Jumlah responden yang sesuai dengan kriteria inklusi pada penelitian ini adalah 42 orang. Distribusi dan frekuensi pterigium berdasarkan karakteristiknya, didapatkan jumlah tertinggi pada kelompok usia 30-39 tahun (28,6%), jenis kelamin laki-laki (54,8%), jenis pekerjaan kelompok 3 (76,2%), durasi paparan sinar matahari ? 4 jam (64,3%), tanpa riwayat pemakaian kacamata (92,9%), dengan riwayat pemakaian topi (52,4%), dengan riwayat keluarga (83,3%), lokasi pterigium okuli dekstra sinistra (78,6%), pada sisi nasal (91,9%), dan derajat II (45,9%). Distribusi dan frekuensi pterigium berdasarkan karakteristiknya diharapkan dapat membantu dalam pencegahan terhadap terjadinya pterigium dan kebutaan akibat pterigium derajat lanjut. Kata kunci: pterigium, karakteristik, distribusi, frekuensi
Different Retinopathy of Prematurity Severity, Onset Therapy and Outcomes in Triplet Babies: A Case Report: Poster Presentation - Case Report - Resident PUTU ANINDYA AGRASIDI; I WAYAN EKA SUTYAWAN; NI MADE AYU SURASMIATI
Majalah Oftalmologi Indonesia Vol 49 No S2 (2023): Supplement Edition
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/1de12078

Abstract

Introduction : Retinopathy of prematurity (ROP) is a vasoproliferative disease of the premature infants, characterized by abnormal vascularization at the junction of vascular and avascular retina. Intravitreal anti-VEGF injection is one of promising management of ROP. The aim is to present the therapy outcomes of triplet babies with different severity and onset therapy. Case Illustration : This case shows ROP in triplets born at 25-26 weeks gestational age. First baby, weighed 630 g with Bilateral Stage 2 Zone II Posterior with Plus Disease treated with intravitreal ranibizumab injection at 11 weeks (PMA 36-37 weeks). Second baby, weighed 620 g and get bilateral intravitreal ranibizumab injection a week after first baby, left eye got worse on first week, but getting better on the last follow up. Third Baby, weighed 750 g with bilateral Stage 3 Zone I with Plus Disease (worst eye condition), but because he had worst general condition, so the latest got screening, got no intervention. Two babies were treated with anti-VEGF therapy – bevacizumab. All babies has outcome regression, no recurrence of ROP in those short term end point, and no adverse reactions were observed until the last follow up at 27 weeks old (PMA 52-53 weeks) recorded for all babies. Discussion : Conclusion : Primary prevention through well-managed screening programme for premature infants was the more effective way to manage the ROP. Intravitreal anti-VEGF treatment could be promising for management of ROP if it was given on the right time and early stadium.
Co-Authors I Wayan Eka Sutyawan Ni Made Ayu Surasmiati